Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia
Debut, the biotech beauty leader, has secured $20M in investment to accelerate the expansion of its proprietary, AI-based ingredient discovery platform to advance skin longevity innovation and scale its formulation business in the US and Asia.
- 26 08 2025
- |
Discover Insights and Trends
Debut Raises $20M to Fast-track AI Ingredient Discovery in Skin Longevity and Grow its Formulation Business in the US and Asia
- 26 08 2025
- |
Hydroleap Secures USD 4.75 million in Latest Funding Round to Accelerate Sustainable Water Technologies in APAC
- 30 07 2025
- |
Portfolio Spotlight Ep 6: Hummingbird Bioscience with Co-Founder & CEO, Piers Ingram
- 28 07 2025
- |
Augmentus Raises $11M to Scale Physical AI for High-Mix, Complex Robotic Surface Finishing and Welding
- 09 07 2025
- |
Tacta Systems Announces $75 million in Funding to Bring Dextrous Intelligence to Robot
- 26 06 2025
- |
Multiplier Holdings Launches With $27.5 Million in Funding to Accelerate the AI Journey for Professional Services Firms
- 23 06 2025
- |
Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management
- 05 06 2025
- |
Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
- 03 06 2025
- |
Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy
- 20 05 2025
- |
